Seeking Alpha

Actavis, which is being acquired by Watson Pharmaceuticals (WPI +0.2%), says that on June 29 it...

Actavis, which is being acquired by Watson Pharmaceuticals (WPI +0.2%), says that on June 29 it received tentative approval from the FDA for Guanfacine Extended-Release Tablets, a generic equivalent to Shire's (SHPGY -2.5%) Intuniv. Intuniv had US sales of approximately $342M for the 12 months ending March 31.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector